![Page 1: 2019 Preliminary Results · Over 850 systems sold into over 500 medical institutions • Revenue steady at £2.6m • Important multiple sales to ... • Difficult purchasing market](https://reader036.vdocuments.net/reader036/viewer/2022071106/5fe0aa307d0b995d25077619/html5/thumbnails/1.jpg)
2019 Preliminary Results
Transforming ultrasound scanning through AI
Year ended 31 December 2019 (unaudited)
![Page 2: 2019 Preliminary Results · Over 850 systems sold into over 500 medical institutions • Revenue steady at £2.6m • Important multiple sales to ... • Difficult purchasing market](https://reader036.vdocuments.net/reader036/viewer/2022071106/5fe0aa307d0b995d25077619/html5/thumbnails/2.jpg)
• Revenue up 11% to £5.9m
• Gross margin strong at 58%
• Close to divisional EBITDA breakeven
• North America revenue up 53% to £2.7m
• SonoSite co-marketing agreement signed
SIMULATION BASED TRAINING IN THE CLASSROOM AI BASED IMAGE ANALYSIS IN THE CLINIC
Providing a range of hi-fidelity simulators for educating and training ultrasound practitioners and improving patient care by raising scanning standards around the world
Developing a range of AI-based software for real-time guidance and image analysis during ultrasound scanning,
to improve the speed and standard of scanning worldwide
SIMULATION DIVISION CLINICAL AI DIVISION
• First OEM contract signed
• All milestones on target
• Second product at regulatory phase
and in commercial discussions
• Image database grown to 4m images
HIGHLIGHTS OF THE YEAR
![Page 3: 2019 Preliminary Results · Over 850 systems sold into over 500 medical institutions • Revenue steady at £2.6m • Important multiple sales to ... • Difficult purchasing market](https://reader036.vdocuments.net/reader036/viewer/2022071106/5fe0aa307d0b995d25077619/html5/thumbnails/3.jpg)
3
SIMULATION DIVISION
Training to the highest standards
![Page 4: 2019 Preliminary Results · Over 850 systems sold into over 500 medical institutions • Revenue steady at £2.6m • Important multiple sales to ... • Difficult purchasing market](https://reader036.vdocuments.net/reader036/viewer/2022071106/5fe0aa307d0b995d25077619/html5/thumbnails/4.jpg)
Over 850 systems sold into over 500 medical institutions
• Revenue steady at £2.6m• Important multiple sales to
Romanian universities• Encouraging sales in Iberia
ROW:
Simulation Division
North America:
• Revenue up 53% to £2.7m• Strong BodyWorks and HeartWorks
sales• SonoSite agreement signed• Support team expanded
UK:
• Revenue down 27% to £0.7m• Difficult purchasing market despite clinical demand• Q1 2020 showing encouraging early recovery
![Page 5: 2019 Preliminary Results · Over 850 systems sold into over 500 medical institutions • Revenue steady at £2.6m • Important multiple sales to ... • Difficult purchasing market](https://reader036.vdocuments.net/reader036/viewer/2022071106/5fe0aa307d0b995d25077619/html5/thumbnails/5.jpg)
Simulation division revenue growth since 2013
United Kingdom19%
North America32%
Rest of World49%
Geographic Revenue
2018
United Kingdom
11%
North America45%
Rest of World44% Geographic
Revenue2019
2013 2014 2015 2016 2017 2018 2019
H2 0.7 1.1 1.2 2.0 2.1 2.8 2.6
H1 0.6 0.7 1.1 1.3 2.1 2.5 3.3
-
1.0
2.0
3.0
4.0
5.0
6.0
7.0
Simulation Division Revenue
H1 H2
£5.3m
£4.2m
£3.3m
£2.3m
£1.8m
£1.3m
£5.9m
12%
44%
![Page 6: 2019 Preliminary Results · Over 850 systems sold into over 500 medical institutions • Revenue steady at £2.6m • Important multiple sales to ... • Difficult purchasing market](https://reader036.vdocuments.net/reader036/viewer/2022071106/5fe0aa307d0b995d25077619/html5/thumbnails/6.jpg)
BodyWorks for COVID-19
6
• Post year end launch
• New version of BodyWork’s PoCUS simulator
released for COVID-19
• Enables hands-on training for frontline
clinical staff to use lung ultrasound to
diagnose COVID-19 disease
• Free upgrade for all hospital users
• First systems in the UK and US live on 23
March 2020
![Page 7: 2019 Preliminary Results · Over 850 systems sold into over 500 medical institutions • Revenue steady at £2.6m • Important multiple sales to ... • Difficult purchasing market](https://reader036.vdocuments.net/reader036/viewer/2022071106/5fe0aa307d0b995d25077619/html5/thumbnails/7.jpg)
CLINICAL AI DIVISION
Speeding up scanning and reducing misdiagnosis
![Page 8: 2019 Preliminary Results · Over 850 systems sold into over 500 medical institutions • Revenue steady at £2.6m • Important multiple sales to ... • Difficult purchasing market](https://reader036.vdocuments.net/reader036/viewer/2022071106/5fe0aa307d0b995d25077619/html5/thumbnails/8.jpg)
• First long-term licensing agreement
• with one of the world’s leading ultrasound
manufacturers
• Integrating our AI image analysis
software
• onto a global range of ultrasound systems
• Generating high margin royalty
• Revenues expected from 2021
• Following regulatory approval
• More agreements expected to follow
First global AI licence signed
![Page 9: 2019 Preliminary Results · Over 850 systems sold into over 500 medical institutions • Revenue steady at £2.6m • Important multiple sales to ... • Difficult purchasing market](https://reader036.vdocuments.net/reader036/viewer/2022071106/5fe0aa307d0b995d25077619/html5/thumbnails/9.jpg)
9
![Page 10: 2019 Preliminary Results · Over 850 systems sold into over 500 medical institutions • Revenue steady at £2.6m • Important multiple sales to ... • Difficult purchasing market](https://reader036.vdocuments.net/reader036/viewer/2022071106/5fe0aa307d0b995d25077619/html5/thumbnails/10.jpg)
Proof of Concept
OEM agreement
OEM integration
First revenue expected
Product in development
Regulatory process
ProductAI
PLATFORM
Image analysis product 1
Image analysis product 4
H1 2021
H1 2022
2021
TBC
TBC
TBC
TBC
TBC
TBC
TBC
TBC
TBC
AI software platform A
Image analysis product 6
Image analysis product 9
Image analysis product 2
Image analysis product 5
Image analysis product 7
Image analysis product 3
AI software platform B
AI software platform C
AI software platform D
Image analysis product 4
Image analysis product 6
Image analysis product 9
Multi-platform, multi-licence strategy
10
Launch
Image analysis product 4
OEM version
Non OEM version
![Page 11: 2019 Preliminary Results · Over 850 systems sold into over 500 medical institutions • Revenue steady at £2.6m • Important multiple sales to ... • Difficult purchasing market](https://reader036.vdocuments.net/reader036/viewer/2022071106/5fe0aa307d0b995d25077619/html5/thumbnails/11.jpg)
COVID-19 Impact
• The recent spread of the COVID-19 virus is impacting all regions in which the Group
operates
• There is also considerable uncertainty over the likely duration of the disruption
• To counter any short term slow-down in global simulator sales, we have implemented
several cost-saving measures
• This will enable the Group’s EBITDA in FY2020 to remain in line with expectations
• The outlook for the medium and long term remains unchanged
• Group expects to have sufficient funds to continue its simulation and AI business activities
for 12 months
• When the revenues from its first AI software licence agreement are expected to come on
stream
11
![Page 12: 2019 Preliminary Results · Over 850 systems sold into over 500 medical institutions • Revenue steady at £2.6m • Important multiple sales to ... • Difficult purchasing market](https://reader036.vdocuments.net/reader036/viewer/2022071106/5fe0aa307d0b995d25077619/html5/thumbnails/12.jpg)
FINANCIALS2019 UNAUDITED PRELIMINARY RESULTS
![Page 13: 2019 Preliminary Results · Over 850 systems sold into over 500 medical institutions • Revenue steady at £2.6m • Important multiple sales to ... • Difficult purchasing market](https://reader036.vdocuments.net/reader036/viewer/2022071106/5fe0aa307d0b995d25077619/html5/thumbnails/13.jpg)
CONSOLIDATED INCOME STATEMENT
13
![Page 14: 2019 Preliminary Results · Over 850 systems sold into over 500 medical institutions • Revenue steady at £2.6m • Important multiple sales to ... • Difficult purchasing market](https://reader036.vdocuments.net/reader036/viewer/2022071106/5fe0aa307d0b995d25077619/html5/thumbnails/14.jpg)
CONSOLIDATED STATEMENT OF FINANCIAL POSITION
14
![Page 15: 2019 Preliminary Results · Over 850 systems sold into over 500 medical institutions • Revenue steady at £2.6m • Important multiple sales to ... • Difficult purchasing market](https://reader036.vdocuments.net/reader036/viewer/2022071106/5fe0aa307d0b995d25077619/html5/thumbnails/15.jpg)
CONSOLIDATED STATEMENT OF CASH FLOWS
15